GEORGE Z. SINGAL, District Judge.
This matter is set for a bench trial, to commence on August 23, 2016, on the damages owed by Defendant Triple R Veterinary in connection with its stipulated liability under the IDEXX Reference Laboratory Preferred Customer Agreement with a start date of January 1, 2012 (the "Parent Agreement"). The parties have filed a variety of pretrial motions. Specifically, before the Court are the following motions: (1) Defendant's Motion to Retain Confidentiality Designations (ECF No. 20); (2) Defendant's Motion in Limine Regarding Measure of Plaintiffs' Damages (ECF No. 50); and (3) Plaintiffs' Motion in Limine to Exclude Extrinsic Evidence (ECF No. 51). For reasons briefly explained herein, the Court DENIES each of these three Motions (ECF Nos. 20, 50 & 51). All of these denials are made without prejudice to either party renewing their objections at trial as particular evidence is presented. Additionally, as explained below, to the extent that the motions raise issues that the Court believes go to the heart of the parties' remaining dispute, the Court concludes those issues are not amenable to resolution via motions in limine and can only be resolved on the more fully developed post-trial record.
Via this Motion, Defendant Triple R Veterinary, PLLC ("Triple R") seeks to retain the designation of "Confidential—Attorneys' Eyes Only" that it applied to 243 pages of its document production (TRV00001-TRV00243) that relate to its ongoing business relationship with Antech Diagnostics (hereinafter, the "Antech documents").
After taking the Motion to Retain Confidentiality Designations under advisement, the Court asked for the Antech documents to be submitted in camera for review. Having now reviewed the documents as well as the written submissions of the parties in connection with the Motion to Retain Confidentiality Designations, the Court DENIES the Motion, finding that Triple R waived the designation and that, in any event, it has not shown good cause for its ongoing categorical designation of the Antech documents as "Attorneys' Eyes Only."
The Consent Confidentiality Order (ECF No. 18) entered in this case allows for the production of materials with the designation "Confidential—Attorneys' Eyes Only." It also provides that if opposing counsel objects to any designations, it may serve an objection on the designating party within thirty days. (Confidentiality Order ¶ 8(a).) The Confidentiality Order then provides for a fifteen day period to meet and confer. If an agreement is not reached that resolves the objection, the Order clearly requires the designating party to file a motion to retain its designation within thirty days of service of the objection and "show good cause for the . . . designation." (Confidentiality Order ¶ 8(c).) "The failure to file the motion waives the . . . CONFIDENTIAL—ATTORNEYS' EYES ONLY designation." (
Here, IDEXX objected to the designation of the Antech documents on February 18, 2016. By all accounts, the parties conferred, but no resolution was reached. Both sides agree that the thirty-day deadline for Triple R to file its motion passed on March 21, 2016. Triple R then filed the pending Motion ten days later on March 31, 2016. Thus, under the plain and clear terms of the Confidentiality Order, the designation was waived.
Assuming the Court could somehow excuse this delay, the Court nonetheless concludes that the Motion does not categorically provide good cause for the continuing designation. First, Triple R maintains that the documents are irrelevant to the issues remaining for trial. On this point, the Court disagrees. For reasons more fully explained in the Court's ruling on Defendant's Motion in Limine Regarding Measure of Plaintiffs' Damages (ECF No. 50), the Court does believe that at least some of the Antech documents may be relevant under IDEXX's theory of damages, and the Court intends to allow IDEXX to present evidence in support of that theory at trial. As explained in Plaintiffs' June 6, 2016 Proffer, the Court is also satisfied that IDEXX may be able to establish that some of the Antech documents are relevant to the credibility of certain witnesses Triple R has listed as trial witnesses.
Second, Triple R maintains that any lifting of its confidentiality designation on the Antech documents will give IDEXX "an unfair competitive advantage," given that IDEXX and Antech are "the dominant players" in a "narrow industry." (Trautwein Decl. (ECF No 20-1) ¶ 11.) While even IDEXX acknowledges that Antech's pricing information (a subset of the information contained within the Antech documents) "potentially raises competitive concerns," the Court is satisfied based on the exhibits submitted by Plaintiffs that similar information related to Antech pricing has been publicly disclosed in the past. (Pls. Response (ECF No. 22) at 6-7 & Exs. A & B.) Thus, Triple R simply has not met its burden of establishing good cause on a timely basis to support the categorical sealing of the Antech documents.
To the extent it aids the parties in preparation for the upcoming public trial, the parties are advised that the Court anticipates that each and every exhibit received at trial will be publicly available. Upon a showing of good cause, the Court may consider allowing the submission of a redacted document as the exhibit if the redacted version will still allow the Court to consider and decide the damages issues being presented. However, the parties should not anticipate that the Court will allow the sealing of exhibits simply because they were produced with a confidentiality designation.
Defendant seeks a pretrial ruling that the measure of IDEXX's lost profits as a result of Triple R's breach must be calculated by using the enumerated minimum qualifying annual purchase levels in the contract
Given the undisputed application of Maine law to the breach of contract at issue here, the purpose of the damage award is to "`place the plaintiff in the same position as that enjoyed had there been no breach.'"
Given the exclusivity terms of the breached contract, IDEXX is entitled to present evidence of how much it would have actually earned had Triple R complied with the exclusivity term, including the portion of that term that required Triple R to transition "practices acquired after the Start Date." In its Response to this Motion (ECF No. 44), IDEXX represented that seven such additional practices were added. (
Quite simply, it remains to be seen whether the preponderance of the admitted evidence will amount to a reasonably certain estimate that the Court can use to award IDEXX the higher amount of damages it seeks for Triple R's breach.
Plaintiffs ask the Court for a pretrial exclusion of "evidence and arguments related to an exclusive remedy or liquidated damages clause" and a declaration that the Parent Agreement is "unambiguous and fully integrated," such that "no extrinsic or parol evidence is admissible to interpret or alter" the Parent Agreement. (Pls. Mot. (ECF No. 51) at 2 & 10.) Defendant objects to this request and lays out an interpretation of the Parent Agreement that is diametrically opposite to Plaintiffs' interpretation. In Defendant's view, the Default provision of the Parent Agreement should be enforced as a "liquidated damages clause." Defendant also asks that this Court "reserve determination regarding the admissibility of any proffered extrinsic evidence on contract interpretation issues until [the evidence is] offered at trial." (Def. Response (ECF No. 47) at 6.)
The Court generally agrees with the approach suggested by Defendant and will adopt this approach by DENYING Plaintiffs' Motion in Limine to the extent that it seeks categorical exclusion of evidence. To the extent that Plaintiffs' Motion seeks application of the parol evidence rule upon a finding by the Court that the Parent Agreement is an unambiguous, integrated agreement, the Court DENIES this request without prejudice, but notes that it will deal with the issue at trial.
The Court notes that it does appear that on its face the Parent Agreement contains an integration clause:
(Parent Agreement at IDEXX-0000122 (ECF No. 51-1 at PageID # 526).)
The Parent Agreement also contains a provision entitled "Default," which reads:
(Parent Agreement at IDEXX-0000123 (ECF No. 51-1 at PageID # 527).) Defendant asserts that this Default provision is the liquidated damages clause it seeks to enforce as the cap on Plaintiffs' damages. At trial, it will be Defendant's burden, as the party seeking to enforce a liquidated damages provision, to prove its interpretation of the clause's meaning, as well as the clause's validity, under the applicable two-part test.
The Court notes that in its initial review of the record now available, the parties have stipulated that Triple R elected to breach its exclusivity obligations under the Parent Agreement, and there is no disagreement that Triple R did so by signing an exclusive contract with an IDEXX competitor. Given these circumstances, the Court fails to see how Triple R can invoke the Default provision as a limitation on IDEXX's available remedies for Triple R's breach. Nonetheless, the Court recognizes this issue as potentially dispositive and believes it is best resolved on a developed factual record, not a redacted motion in limine.
Therefore, the Court DENIES Plaintiffs' Motion in Limine to Exclude Extrinsic Evidence (ECF No. 51). The Court's denial is without prejudice to Plaintiff's renewing any specific objections at trial as evidence is presented. The Court anticipates issuing its final ruling on the application of the parol evidence rule to the Parent Agreement in connection with the issuance of its post-trial findings of fact and conclusions of law.
SO ORDERED.